Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

November 01, 2018 | Daily News

CMS backtracked on a controversial proposal to overhaul how doctors are paid for office visits but finalized policies to expand telehealth services in the 2019 Physician Fee Schedule and Quality Payment Program final rule released Thursday (Nov. 1).

November 01, 2018 | Daily News

The final physician fee schedule and Part B pay rule cuts Medicare pay to doctors for administering drugs from 106 percent of wholesale acquisition cost to WAC plus 3 percent, despite opposition from doctors and House Republican committee chairs.

November 01, 2018 | Daily News

CMS on Thursday (Nov. 1) finalized changes for the next round of competitive bidding for durable medical equipment, as well as reimbursement rates for suppliers once the current round of competitive bidding ends Dec. 31 until the next round kicks in.

November 01, 2018 | Daily News

HHS announced Thursday (Nov. 1) the death of Dan Best, who was HHS Secretary Alex Azar's senior adviser on drug price policy. The department did not give a cause of death or Best's age.

November 01, 2018 | Daily News

The White House budget office on Wednesday (Oct. 31) finished its review of the final version of the Medicare Physician Fee Schedule and Part B 2019 pay rule.

November 01, 2018 | Daily News

FDA unveiled a sweeping action plan that aims to spur innovation in animal and plant biotechnology and establish the agency as a global leader in the oversight of plant biotechnology by making FDA's relevant regulatory pathways more predictable, efficient and transparent.

October 31, 2018 | Daily News

The Health Resources and Services Administration proposed on Wednesday (Oct. 31) to push up the implementation date of the 340B ceiling price and penalties rule to Jan. 1, as the administration determined that finalizing the rule won't interfere with HHS' overall drug pricing strategy -- even though the agency had previously said that strategy necessitated pushing the rule back to July 2019.

October 31, 2018 | Daily News

FDA device center chief Jeff Shuren said the agency will release a white paper that details its thinking on machine learning in medical software.

October 31, 2018 | Daily News

FDA approved Novartis’ biosimilar of AbbVie’s blockbuster arthritis drug Humira, which is the world’s bestselling prescription drug, on Tuesday (Oct. 30).

October 30, 2018 | Daily News

Hospitals included in the Trump administration's proposed International Pricing Index demonstration could be forced out of the 340B drug discount program, hospital lobbyist and consultant sources say, but some think that would be an unintended effect of the model and there is disagreement over whether the administration would fix the policy.

October 29, 2018 | Daily News

The White House budget office is reviewing a proposed rule to lower drug prices and reduce out-of-pocket costs by reforming Part D and Medicare Advantage, the office's website states.

October 29, 2018 | Daily News

In a recent report, the Institute for Clinical Economic Review (ICER) determines that extended-release formulations of medications used to treat opioid use disorder cost much more than generic buprenorphine/naloxone while providing only marginal clinical benefit.

October 29, 2018 | Daily News

Eisai Inc. and the Oklahoma Health Care Authority have signed an outcome-based contract to provide the state’s Medicaid program with the epilepsy drug Fycompa, marking the third such pharmaceutical contract signed by the state.

October 28, 2018 | Daily News

CMS released a proposed Medicare Advantage and Part D rule Friday (Oct. 26) that would allow MA plans to cover more telehealth services and would streamline benefits and appeals for dually enrolled beneficiaries.

October 28, 2018 | Daily News

HHS Secretary Alex Azar said President Donald Trump is not backing down from an advance notice of proposed rulemaking that would pilot international price referencing for Medicare Part B drugs.

October 26, 2018 |

HHS Secretary Alex Azar on Friday systematically attacked drug manufacturers’ criticisms of the Trump administration’s plan to implement international price referencing for prescription drugs in Medicare Part B, saying despite strong denunciations, he does not think drug makers will play a “game of chicken” and walk away.

October 26, 2018 | Daily News

HHS Secretary Alex Azar on Friday systematically attacked drug manufacturers’ criticisms of the Trump administration’s plan to implement international price referencing for prescription drugs in Medicare Part B, saying despite strong denunciations, he does not think drug makers will play a “game of chicken” and walk away.

October 26, 2018 | Daily News

A key White House health care official called on Congress to undo changes it made to the Medicare Part D prescription drug donut hole earlier this year, siding with drug makers that are lobbying to unravel the change that increased the industry’s share of costs in the coverage gap.

October 25, 2018 | Daily News

HHS Secretary Alex Azar on Thursday (Oct. 25) proposed that Medicare rely on foreign government drug price controls that two days earlier the White House Council of Economic Advisers compared to Leninism and Maoism.

October 25, 2018 | Daily News

The brand pharmaceutical industry came out swinging against the Trump administration's newly unveiled plan to use an international pricing index to pay for physician-administered drugs in Medicare, likening the idea to price controls imposed by foreign countries with socialized health care.

Pages